Mednet Logo
CommunityRadiation Oncology

Is there any threshold regarding extraprostatic extension to contraindicate a rectal spacer?

The original study used 50% of positive cores, but the MSKCC nomogram can give a high risk of EPE with just 4-5 positive cores out of 12
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Utah School of Medicine
Answered on · Updated on

This is an important question, and as far as I know there are no data to guide a response. I personally believe that EPE (within reason) is not a contraindication to hydrogel. One would expect the extension, capsule and prostate to lift in unison, depending on where the extension is. The NCCN guidel...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Radiation Medical Group
Answered on

Fascinating question: And as several prior good answers have noted, ECE happens routinely, no matter how tightly we screen the patients. So certainly, from time to time, there will be at least a scattering of bad cells on the "wrong side of SpaceBlob."

My indication for no spacer to date has been ro...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Tennessee Oncology
Answered on

Let's clearly state the concern here: are there circumstances in which our attempt to lower rectal dose and complications may lead to a higher risk of disease recurrence? And if the chronic bowel toxicity rate is lowered by an absolute value of 5%, but the recurrence rate is raised by 1%, is that an...

Join for free or sign in to see the full answer